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From the Editor’s Desk
FOCUS ON METROPOLITAN 
HOSPITALS
Metropolitan hospitals are vital to our 
hospital system. For every tertiary referral 
hospital in our national capitals, there are 
at least two metropolitan hospitals. Despite 
their dominance, they remain the poor 
cousins of the hospital family, and this 
relative poverty drew senior clinicians and 
bureaucrats to a meeting in Sydney 
recently.*
The perennial buzz words — workforce 
shortages, quality and safety, risk 
management, training opportunities, 
effectiveness and efficiency — peppered 
the presentations. Emergent themes included 
the declining viability of clinical services, the 
effects of specialism, dissatisfaction among 
professionals, a chronic shortage of both 
senior and junior clinical staff, and the highly 
inadequate coverage of clinical services “after 
hours” (which amounts to more than 100 
hours per week!). 
The meeting threw up potential solutions: 
changing community expectations that every 
hospital should provide services for all 
clinical contingencies, and abandoning the 
“silo ethos” of hospitals in favour of clinical 
networks with precedence over individual 
institutions. Interestingly, one suggestion 
from the floor — that some hospitals cease 
to be acute general hospitals and become 
specialised elective centres — was greeted 
by sustained applause.
In short, the consensus for change was 
overwhelming, but expectations blunted.
The meeting also highlighted the 
emergence of a new species, “ the locumist”. 
Medical workforce shortages combined 
with an absence of enforceable professional 
standards has seen commercial enterprises 
provide an expanding pool of low-skilled and 
itinerant locums. These individuals can earn 
up to $200 000 per year, to the chagrin of 
specialists, on whom they call for help, and 
vocational trainees doing the same shift. 
Meanwhile, the drain on the health budget 
runs into millions. 
All in all, there was a refreshing impatience 
with the status quo and an enthusiasm for 
reform. Sadly, delay and indecision may see 
this expectant impatience subside into 
deadening indifference.
Martin B Van Der Weyden
* The Greater Metropolitan Clinical Taskforce, 5th
Metropolitan Hospitals Forum, 5 March 2005.
1
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Letters
Tungiasis in recently arrived 
African refugees
Ashwin Swaminathan,* Iain B Gosbell,† 
Nicholas A Zwar,‡ Mark W Douglas§
* Infectious Diseases Registrar, † Director and 
Associate Professor, § Infectious Diseases Physician, 
Department of Microbiology and Infectious Diseases, 
Liverpool Hospital, South Western Area Pathology 
Service, Locked Bag 7090, Liverpool, NSW 1871; 
‡ Director and Professor of General Practice, Sydney 
South West Area Health Service General Practice 
Unit, Fairfield Hospital, Sydney, NSW. 
Iain.Gosbell@swsahs.nsw.gov.au
TO THE EDITOR: Infestation with the
sandflea Tunga penetrans, or “chigoe flea”, is
rarely encountered in Australia, but has
been noted in children recently arrived
from Central–East Africa. There have been
only two previous Australian case reports of
this parasitic infection, both in adult travel-
lers returning from Africa.1,2
Several families who had been living in
crowded refugee camps in Tanzania under-
went routine screening for infection within
2 weeks of arrival in Australia. Four of 14
children examined had cutaneous lesions
on their feet — mainly on the toes, nail
beds and interdigital spaces (Box). These
lesions were papular, less than 1 cm in
diameter, pale yellow with dark centres,
and were variably painful and/or itchy.
Chronic, adjacent skin and nail bed changes
were evident, as were small, loosely
attached seed-like objects. Papules could be
lifted with a sterile needle, leaving a small,
non-bleeding cavity. Tunga penetrans, with
numerous attached eggs, was identified by
microscopy.
Tungiasis occurs when an impregnated
female sandflea burrows into the unpro-
tected skin of a warm-blooded host. There
is a predilection for the feet, although the
perineum, buttocks and arms may also be
infected.3 The head of the sandflea breaches
the upper dermis to feed on blood vessels,
while the abdomen traverses the epidermis,
with its posterior components (anus, genital
opening and respiratory spiracle) reaching
the surface, forming a papule. Over several
weeks, the flea releases hundreds of eggs
before dying. After hatching, the larvae
thrive in dust, soil and sand; they are found
on beaches and in animal stockyards of
tropical countries.3,4 Infection of pigs and
other livestock, the usual host reservoirs,
has led to significant problems in the live-
stock industry.1,4
Apart from pruritis and pain caused by
local inflammation, morbidity results from
ulceration and secondary bacterial infec-
tion, including tetanus and gas gan-
grene.1,2,4
Fleas can be removed using a sterile
needle and forceps, and secondary compli-
cations prevented with tetanus prophylaxis,
and antibiotics as appropriate. Successful
outcomes with antiparasitic agents, such as
ivermectin and thiabendazole, have also
been recently reported.5
Tungiasis is indigenous to Latin America
and the Caribbean, but was introduced to
Africa, where it is now endemic, and to
parts of South Asia.4 Given the current
influx of African refugees into Australia,
including the tropical north, the obvious
concern is whether Tunga penetrans could
establish itself here.
We encourage medical practitioners deal-
ing with newly arrived African refugees to
examine for tungiasis in their screening
evaluation. If, as suspected, this condition
is prevalent, national infection control
guidelines aimed at preventing establish-
ment of the disease in Australia may be
needed.
1 Ott MB, Charters AD, Bowman RA. Tungiasis:
imported disease. Med J Aust 1980; 2: 623-624.
2 Spradbery JP, Bromley J, Dixon R, et al. Tungiasis in
Australia: an exotic disease threat [letter]. Med J
Aust 1994; 161: 173.
3 Eisele M, Heukelbach J, Van Marck E, et al. Investi-
gations on the biology, epidemiology, pathology
and control of Tunga penetrans in Brazil: 1. Natural
history of tungiasis in man. Parasitol Res 2003; 90:
87-99.
4 Heukelbach J, Araujo F, Oliveira de S, et al. Tungia-
sis: a neglected health problem of poor communi-
ties. Trop Med Int Health 2001; 6: 267-272.
5 Heukelbach J, Eisele M, Jackson A, Feldmeier H.
Topical treatment of tungiasis: a randomized, con-
trolled trial. Ann Trop Med Parasitol 2003; 97: 743-
749. ❏
Incidental finding of 
Dracunculus medinensis in 
Australia
Tulsi Menon
Resident Medical Officer, Department of Orthopaedic 
Surgery, Royal Perth Hospital, 19 Morgan Road, 
Redcliffe, WA 6104 
kaltul@optusnet.com.au
TO THE EDITOR: I report an infection with
Dracunculus medinensis diagnosed inciden-
tally on x-ray. The patient was a Sudanese
immigrant, who had sustained a left knee
joint effusion after falling. During manage-
ment at Royal Perth Hospital, a calcified
lesion with a serpentine appearance was seen
on x-ray within soft tissues near the left knee
joint. Its characteristic appearance, combined
with the patient’s background, led to a diag-
nosis of D. medinensis (known as guinea-
worm), a nematode parasite which causes
dracunculiasis.
The patient’s knee effusion was managed
conservatively and improved within a few
weeks. The effusion was secondary to the fall
and believed to be unrelated to the calcified
D. medinensis.
Transmission of dracunculiasis is through
consumption of contaminated water. The
guinea-worm larvae mature and migrate
towards the skin surface over 1 year (during
which the patient remains asymptomatic),
with over 90% of the worms appearing from
the lower limbs. When in contact with water,
the exposed guinea-worm releases larvae,
and the lifecycle is completed when people
ingest contaminated water.1 If the guinea-
worms die before maturation, they usually
calcify.
The Global Dracunculiasis Eradication
Campaign was established in 1981 with the
aim of eliminating dracunculiasis through
water sanitation efforts.1 With no vaccine or
treatment, prevention is the only method of
eliminating dracunculiasis. Since the cam-
paign was established, the number of people
affected by dracunculiasis has decreased by
98%. Currently, Sudan alone accounts for
73% of cases.1
Our patient migrated to Australia as a
refugee from Sudan during the civil war. Her
village in Sudan had only one source of water
used for daily activities, including drinking.
The patient knew many people with dracun-
culiasis, but did not know she had been
infected.
When calcified guinea-worms are discov-
ered during routine radiological examination,
they usually do not need treatment. Many
people are not aware they have been infected.
Lesions caused by Tunga penetrans, 
the “chigoe” sandflea
A characteristic Tunga penetrans lesion 
(thick arrow), with pale-yellow papule and 
dark centre, and a less obvious lesion (thin 
arrow) with surrounding chronic skin 
changes and multiple, loosely attached 
eggs.
LETTERSMuller reported 89% of patients with calci-
fied guinea-worms were asymptomatic.2
No known previous case of a radiologically
diagnosed calcified guinea-worm has been
reported in Australia. The consequences of
war and famine, with a resultant increase in
refugees and immigrants from affected nations,
is likely to increase the number of incidental
calcified guinea-worms found in non-endemic
countries. This disease may have a significant
impact if affected immigrants arrive during the
incubation period (when asymptomatic) and
the parasite emerges from the skin after immi-
gration (rather than calcifying), similar to the
patient described by Spring.3 Thus, it is imp-
ortant for health personnel to be aware of
dracunculiasis, including its radiological mani-
festations.
Acknowledgements: I thank Mr Alan Prosser, Dr
Mike Ledger, Dr Vera Kinzel, and Dr Song for
encouragement and assistance in preparing this
letter.
1 Greenaway C. Drancunculiasis (guinea worm dis-
ease). CMAJ 2004; 170: 495-500.
2 Muller R. Dracunculus and dracunculiasis. In: Dawes
B, editor. Advances in parasitology. New York, NY:
Academic Press, 1971; 73-140.
3 Spring M, Spearman P. Dracunculiasis: report of an
imported case in the United States. Clin Infec Dis
1997; 25: 749-750. ❏
Vitamin D and adult bone 
health in Australia and New 
Zealand: a position statement
Simon J Vanlint
Lecturer, Department of General Practice, 
University of Adelaide, SA 5005. 
simon.vanlint@adelaide.edu.au
TO THE EDITOR: The Working Group of
the Australian and New Zealand Bone and
Mineral Society, Endocrine Society of Aus-
tralia and Osteoporosis Australia are to be
commended for their clear and succinct posi-
tion statement on vitamin D and bone
health.1 This statement highlights an impor-
tant public health issue which is under-
recognised in this country. Of particular value
is the box of recommendations on high-risk
groups, testing and treatment.
However, I believe an important high-risk
group has been omitted, a group which too
often escapes the notice of the broader medi-
cal community. People with intellectual disa-
bility have been shown to be at particularly
high risk of low vitamin D levels, reduced
bone density and fractures.2-5 The reasons for
this are multifactorial and include poor
mobility, insufficient sun exposure, reduced
muscle mass and strength, problems with
dietary intake, and medications which inter-
fere with vitamin D metabolism.3,4 There is
also some evidence that people with intellec-
tual disability are prone to premature ageing,
together with the health problems associated
with older age in the general population.3
Some conditions which cause or are associ-
ated with intellectual disability are also linked
with hypogonadism and reduced peak bone
mass.4
To add to all of this, several of the above
risk factors, vitamin D deficiency itself, and
the increased incidence of epilepsy in the
population with intellectual disability, also
result in an increased incidence of falls and
trauma.5 This unfortunate combination of
poor bone health and increased risk of falls
and trauma results in a markedly increased
incidence of fracture when compared with
age- and sex-matched controls from the gen-
eral population.2-5
In conclusion, people with intellectual dis-
ability, particularly those with poor mobility
or who are also being treated for epilepsy,
should be added to the list of high risk
groups. It is likely that the relatively simple
steps set out in the position statement
(screening for vitamin D deficiency and sup-
plementation) will result in substantial health
benefits for this small but particularly vulner-
able group of people.
1 Working Group of the Australian and New Zealand
Bone and Mineral Society, Endocrine Society of
Australia and Osteoporosis Australia. Vitamin D and
adult bone health in Australia and New Zealand: a
position statement. Med J Aust 2005; 182: 281-285. 
2 Wagermans A, Fiolet J, van der Linden E, Menheere
P. Osteoporosis and intellectual disability: is there
any relation? J Intellect Disabil Res 1998; 42: 370-374.
3 Foster B, Walkley J, Temple V. Bone mineral density
status of women with intellectual disability. Adapted
Phys Activity Q 2001; 18; 48-59.
4 Schrager S. Osteoporosis in women with disabilities.
J Womens Health  2004; 13: 431-437.
5 Jancar J, Jancar M. Age-related fractures in people
with intellectual disability and epilepsy. J Intellect
Disabil Res 1998; 42: 429-433. ❏
Alvin L K Chia,* Stephen Shumack,† 
Peter Foley‡
* Research Fellow, † Dermatologist, St George 
Dermatology and Skin Cancer Centre, Level 3, 
22 Belgrave St, Kogarah, NSW 2217; 
‡ Dermatologist, St Vincent’s Hospital, 
Melbourne, VIC. sshumack@bigpond.com
TO THE EDITOR: We read with alarm the
extraordinary statements in the position
statement on vitamin D and adult bone
health published recently in the Journal.1
The suggestion that “it is a fallacy that
Australians receive adequate vitamin D from
casual exposure to sunlight” is not true.
The suggested basis for this statement is
an extraordinary extrapolation from a single
study in which a small number of volun-
teers had whole body exposure on one
occasion for 10–15 minutes to midday sum-
mer sun in Boston. It is not possible to
extrapolate in such a way from this single
demonstration, as the effect of shorter expo-
sure times or repeated daily exposures were
not examined. In fact, a study in Australia
showed that the adult population (including
those aged over 70 years) received sufficient
sunlight while using sunscreen to ensure
that no-one was found to have vitamin D
deficiency during the study period.2
While it is well accepted that ultraviolet B
(UVB) radiation is essential for the forma-
tion of vitamin D3 in the skin, it is equally
well established that continued exposure of
vitamin D to UVB radiation results in its
degradation. Hence, the importance of
knowing the effect of lower sun exposures
on vitamin D production.
It is intriguing that the authors of the
position statement recommended a daily
sun exposure dose that they calculate will
produce 1000 IU of vitamin D, but, if sun
exposure is not possible, a vitamin D sup-
plement of at least 400 IU per day.
The high prevalence of vitamin D defi-
ciency among institutionalised older Aus-
tralians is a tragedy, but this cannot be used
Lateral view of left knee joint and 
distal left thigh
A calcified lesion, representing Dracunculus 
medinensis within the soft tissues, is visible 
posterior and lateral to the distal femur 
near the knee joint. The calcification has a 
serpentine appearance: the proximal part 
coiled in appearance, the middle having a 
string-like linear appearance, and the distal 
part having dense curvilinear opacity.52 MJA • Volume 183 Number 1 • 4 July 2005
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LETTERSas the basis of advice for the general popula-
tion who do receive daily sun exposure and
appear to be the target of the statement. Nor
can the mild vitamin D deficiency found in
a single study in southern Victoria be used
to recommend sun exposure in more north-
ern Australian climes. Finally, while vitamin
D supplementation has been shown to
reduce the risk of fractures in the elderly, the
proposed beneficial effect of deliberate sun
exposure has not been demonstrated.
Recently, a joint position statement was
approved by the Australian and New Zea-
land Bone and Mineral Society, Oste-
oporosis Australia, the Australasian
College of Dermatologists and the Cancer
Council Australia. This included the state-
ment that “The majority of Australians
generally have sufficient ultraviolet radia-
tion exposure to enable adequate vitamin
D production . . . to form and maintain
healthy, strong bones”.3 This statement,
endorsed only a few weeks ago, is in
obvious conflict with the position state-
ment from the same organisations that was
published in this Journal. The latter puts
the vast majority of Australians at further
risk of skin cancers, which are already
epidemic in our country.4
1 Working Group of the Australian and New Zealand
Bone and Mineral Society, Endocrine Society of Aus-
tralia and Osteoporosis Australia. Vitamin D and
adult bone health in Australia and New Zealand: a
position statement. Med J Aust 2005; 182: 281-285. 
2 Marks R, Foley PA, Jolley D, et al. The effect of
regular sunscreen use on vitamin D levels in an
Australian population. Results of a randomized con-
trolled trial. Arch Dermatol 1995; 131: 415-421.
3 Risks and benefits of sun exposure position statement.
Approved by the Australian and New Zealand Bone
and Mineral Society, Osteoporosis Australia, Australa-
sian College of Dermatologists and the Cancer Council
Australia. Sydney: Osteoporosis Australia, 2005. Availa-
ble at: http://www.osteoporosis.org.au/files
ccrisksandbenefitsMarch8.pdf (accessed May 2005).
4 Marks R. Epidemiology of non-melanoma skin can-
cer and solar keratoses in Australia: a tale of self-
immolation in Elysian fields. Australas J Dermatol
1997; 38 Suppl 1: S26-S29. ❏
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John D Wark††
* Associate Professor, Endocrinology, University 
of NSW, Sydney, NSW; † Professor and Director, 
Bone and Mineral Research Program, Garvan Institute 
of Medical Research, Sydney, NSW; ‡ Associate 
Professor of Physiology, ** Professor of Rheumatology, 
University of Sydney, NSW; § Associate Professor, 
School of Health Sciences, Deakin University, 
Melbourne, VIC; ¶Senior Research Fellow, Clinical 
and Biomedical Sciences: Barwon Health, The 
University of Melbourne, PO Box 281, Geelong, 
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IN REPLY: We agree with Vanlint that any
individual who has limited mobility, or is
housebound or institutionalised, is at risk of
vitamin D deficiency, as highlighted in Box 3
of the position statement.1 Disability in gen-
eral is likely to be a risk, with motor disabil-
ity as well as intellectual disability liable to
limit sun exposure. The problem may be
further exaggerated by any increased risk of
falls or convulsions.
Chia and colleagues have raised important
issues. After a number of meetings, the Can-
cer Council of Australia, the Australasian
College of Dermatologists and the Australian
and New Zealand Bone and Mineral Society
developed a considered consensus statement
on vitamin D deficiency, risk of skin cancers
and sunlight exposure, which was published
at <http://www.cancer.org.au/documents/
Risks_Benefits_Sun_Exposure_MAR05.pdf>.
This document refers to the position state-
ment published in this Journal in relation to
sun-exposure guidelines for vitamin D.
Chia and colleagues’ objection to the
abstract of this position statement appears
ill-founded. If “a significant number of
Australians are deficient in vitamin D”,
then it follows logically that “it is a fallacyMJA • Volume 183 Number 1 • 4 July 2005 53
LETTERSthat Australians receive adequate vitamin
D from casual exposure to sunlight”, as
sunlight is the main source of vitamin D in
Australia. The significant number of Aus-
tralians deficient in vitamin D are not the
majority, as was clearly shown in the arti-
cle, so this statement does not conflict
with the complementary statement in the
risks and benefits statement.
We stand by our original claim that a
number of groups in the Australian com-
munity have a high prevalence of vitamin
D deficiency, including elderly men with
hip fracture (63%), Muslim women (68%),
elderly ambulant men with prostate cancer
(34%), “healthy” elderly men living in
Southern Sydney (16%), healthy commu-
nity-dwelling, ambulatory women in Gee-
long (20% in the age group 20–39 years,
increasing to 53% in older age groups),
men and women (some with psychiatric
disorders) in south-east Queensland
(23%), and even pregnant women in
south-eastern Australia (7%) (references
are available from the authors on request).
As noted in the position statement, and
by Chia and colleagues, continued expo-
sure to ultraviolet (UV) radiation may lead
to degradation of pre-vitamin D, so that
short exposures are likely to be more
efficient. This degradation is marked only
at relatively high UV doses.2 Studies that
used lower UV doses2,3 produced indirect
UV equivalence data similar to those
quoted in the position statement.1 As the
relationship between UV exposure and
vitamin D dosage varies from person to
person, and as sun exposure is also likely
to be variable and on most days, rather
than every day, the recommendation that
vitamin D supplementation be at least
400 IU/day in people likely to be at risk of
inadequate skin-derived vitamin D is
entirely appropriate.
We strongly agree with Chia and col-
leagues about the need to avoid sun dam-
age while still obtaining the small amount
of sun exposure needed to make adequate
vitamin D, which is why the position
statement advocates short exposures, eas-
ily achieved by casual exposure, and reiter-
ates other Sun-Safe messages, such as
avoidance of exposure in peak UV periods
and the use of sunscreens where appropri-
ate.
1 Working Group of the Australian and New Zealand
Bone and Mineral Society, Endocrine Society of
Australia and Osteoporosis Australia. Vitamin D and
adult bone health in Australia and New Zealand: a
position statement. Med J Aust 2005; 182: 281-285. 
2 Davie M, Lawson DE. Assessment of plasma 25-
hydroxyvitamin D response to ultraviolet irradiation
over a controlled area in young and elderly subjects.
Clin Sci (Lond) 1980; 58: 235-242.
3 Chel VGM, Ooms ME, Popp-Snijders C, et al. Ultra-
violet irradiation corrects vitamin D deficiency and
suppresses secondary hyperparathyroidism in the
elderly. J Bone Miner Res 1998; 13: 1238-1242. ❏
Outcome of overseas 
commercial kidney 
transplantation: an Australian 
perspective
Deborah J Verran
Senior Transplant Surgeon, Royal Prince Alfred 
Hospital, Missenden Road, Camperdown, NSW 2050. 
deborah@email.cs.nsw.gov.au
TO THE EDITOR: A recent editorial by
Mathew et al1 and an article by Kennedy et
al2 tackle the issue of commercial kidney
transplantation.
In their editorial, Mathew and col-
leagues conclude that if the nationwide
Australian deceased donor organ donation
rate approached South Australian levels,
dialysis patients would not travel overseas
to purchase renal allografts.1 I believe that
this statement oversimplifies the situation
with respect to organ trafficking and the
motives behind patients’ acceptance of
this option.
Organ trafficking is illegal under all
state and territory laws within Australia
and hence cannot occur. In a number of
other countries around the world this is
not the case. Although laws have been
introduced in India, this has not necessar-
ily led to cessation of trafficking in kid-
neys.3 Compounding this, the option of
purchasing an organ is becoming more
readily accessible by means of an increas-
ing number of Internet sites.4,5
What motivates patients to go through
with purchasing an organ overseas is not
explored either in the editorial by Mathew
et al1 or the article by Kennedy et al.2
Kennedy et al do not state whether any of
the patients who travelled overseas for a
kidney had been deemed not fit to be on
the renal transplant waiting list in New
South Wales. They also do not give the
waiting time on dialysis for each patient
before he or she decided to travel over-
seas. What is clear is that only patients
who can afford to pay the US$70 000 or
more currently quoted for a renal allograft
will be the ones who end up travelling
overseas.
It would be nice to think that, with an
increased organ donor rate in Australia,
patients will no longer travel overseas to
purchase organs. However, the ready
availability of the commodity in not-too-
distant countries and the increasing ease
of access to this organ trade, combined
with sufficient cash, will mean that there
is no major barrier to some individuals.
1 Mathew TM, Faull RJ, Snelling P. The shortage of
kidneys for transplantation in Australia. Med J Aust
2005; 182: 204-205. 
2 Kennedy SE, Shen Y, Charlesworth JA, et al. Out-
come of overseas commercial kidney transplanta-
tion: an Australian perspective. Med J Aust 2005;
182: 224-227. 
3 Goyal M, Mehta RL, Schneiderman LJ, Sehgal AR.
Economic and health consequences of selling a
kidney in India. JAMA 2002; 288: 1589-1593.
4 Yeson Transplant Network — China Transplant
Information. Available at: http://www.yeson.com.tw
(accessed Mar 2005).
5 Magnifica Libertad Incorporated, The Philippines.
Available at: http://www.liver4you.org (accessed
Mar 2005). ❏
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IN REPLY: We agree that the motives for
organ trafficking are complex. The reasons
that people choose to travel overseas to
obtain an organ was not addressed in our
article on this occasion, but some possible
reasons may be self evident given the long
waiting time, especially in New South
Wales. Our aim was to alert our colleagues
to the increased risks associated with
overseas commercial transplant proce-
dures so that they could ensure that their
patients were fully informed when making
a decision.
Most of our patients were on the wait-
ing list, and the time on dialysis was
detailed in Box 2 in our article.1 However,
two were not on the waiting list — one
had a pre-emptive transplant and another
was not on the list because of age-related
medical problems.
1 Kennedy SE, Shen Y, Charlesworth JA, et al. Out-
come of overseas commercial kidney transplanta-
tion: an Australian perspective. Med J Aust 2005;
182: 224-227. ❏54 MJA • Volume 183 Number 1 • 4 July 2005
LETTERSThe shortage of kidneys for 
transplantation in Australia
Raymond F Raper,* Elizabeth Fugaccia,† 
Yahya Shehabi‡
* Board Member, † Member, ‡ Chairman, NSW Regional 
Committee, Joint Faculty of Intensive Care Medicine, 
117 Alexander Street, Crows Nest, NSW 2065. 
yshehabi@ozemail.com.au
TO THE EDITOR: We are writing in
response to the pejorative, unhelpful and
somewhat misleading editorial “The shortage
of kidneys for transplantation in Australia”.1
There are many possible reasons for lower
organ donation rates in Australia. Several Aus-
tralian initiatives have led the way in reducing
the incidence of severe, traumatic brain inju-
ries. These include the compulsory wearing of
seat belts and helmets, random breath testing,
and a zero blood alcohol limit for inexperi-
enced drivers. Intensive care medicine is better
structured and organised in Australia and New
Zealand than in most of the countries cited by
Mathew et al, with higher organ donation
rates. Intensive care outcomes in Australia are
world-leading. So the donor rate may be lower
because patient outcomes are better. A com-
prehensive chart audit of donor potential in
New South Wales carried out under the super-
vision of the Organ Donation Network NSW/
ACT, identified very few missed donors (T
Wills, Manager, Organ Donation Network
NSW/ACT, personal communication), and a
Victorian audit has suggested that the donor
pool may be much lower in Australia than
previously estimated.2
Similarly, organ donation rates will appro-
priately vary considerably among hospitals. To
improve outcomes, critically ill patients are
transported to centres with specific experience
and expertise, resulting in a preponderance of
potential donors in hospitals with trauma and
neurosurgical services compared with hospi-
tals lacking these. The intensive care commu-
nity supports these life-saving initiatives,
notwithstanding the effect they may have on
organ donation potential.
In fact, the principal “barrier” to organ dona-
tion in Australia appears to be the consent rate.
From 2000 to 2004, 44% of families declined
organ donation when faced with an actual
rather than a hypothetical request.3
The intensive care community represents the
interests of critically ill patients and their fami-
lies. We will continue our best endeavours to
improve both the survival and quality of life of
patients suffering devastating brain injuries
(our performance standard). When all brain
function ceases, despite our best efforts, we will
continue to facilitate organ donation, in discus-
sion with the family, and in consideration of the
patient’s known or projected wish. The inten-
sive care community has led the way in devel-
oping organ donation-related practice
guidelines4 and in related education. Australian
Donor Awareness Program — Training
(ADAPT) workshops are now a compulsory
component of Fellowship of the Joint Faculty
of Intensive Care Medicine training. The edit-
orial implication of poor performance and lack
of commitment is inaccurate and offensive.
1 Mathew T, Faull R, Snelling P. The shortage of
kidneys for transplantation in Australia. Med J Aust
2005; 182: 204-205. 
2 Opdam HI, Silvester W. Identifying the potential
organ donor: an audit of hospital deaths. Intensive
Care Med 2004; 30: 1390-1397.
3 Alvaro C. Identification and review of potential organ
donors — 2004 summary report. Sydney: Organ
Donation Network NSW/ACT, 2004.
4 Australian and New Zealand Intensive Care Society.
Recommendations concerning brain death and
organ donation. 2nd ed. Melbourne: ANZICS, 1998.
Available at: http://www.anzics.com.au/files/brain_
death_organ_donation.pdf (accessed Jun 2005). ❏
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IN REPLY: We regret that Raper et al have
misinterpreted our editorial on the shortage
of donor kidneys in Australia.1 We are par-
ticularly concerned and indeed mystified by
their last statement, where they state that we
implied that “poor performance and . . . lack
of commitment” were to blame. This was in
no manner our message. Rather, we sought
to emphasise that all possibilities to optimise
local donation rates should be explored, so
desperate patients seeking grafts from
potentially dangerous overseas sources need
not expose themselves to serious potential
morbidity and mortality.
We consider that our intensive care col-
leagues perform superbly under the most
difficult of circumstances when managing
potential organ donation. We understand they
are often unsupported with managing poten-
tial donations while they must at the same
time deal with the grieving family, and the
immediate demands of treating other seri-
ously ill patients. We simply suggest that
problems within the system (for example,
differences between states in the number of
intensive care beds per head of population or
in the provision of specifically funded donor
coordinators) that might hinder increasing
organ donation should be carefully examined.
We believe it is unhelpful to suggest that
the South Australian experience should sim-
ply remain unexplained. In the article by
Opdam and Silvester (cited by Raper et al), of
112 potential donors, 46 were considered
medically suitable unrealised potential
donors, and their estimated maximal poten-
tial donor rate was 30 per million,2 remarka-
bly similar to the rates seen in Spain (the
country with the highest organ donor pro-
curement rate) and South Australia. We agree
with the conclusions of Opdam et al that “an
increase in the organ donation rate may be
possible through increasing consent and the
identification and support of potential
donors”. As they also state, this would require
substantial changes in clinical practice, with
resource and ethical complications
We did not mean to offend our intensivist
colleagues. We merely suggest that we all need
to assess the systems in which donation occurs
and attempt to improve donation rates, for the
sake of the many desperate people awaiting
organ transplants in this country.
1 Mathew T, Faull R, Snelling P. The shortage of
kidneys for transplantation in Australia. Med J Aust
2005; 182: 204-205. 
2 Opdam HI, Silvester W. Identifying the potential
organ donor: an audit of hospital deaths. Intensive
Care Med 2004; 30: 1390-1397. ❏
Detention for tuberculosis: 
public health and the law
A Medical Registrar and a 
Respiratory Physician
A New South Wales Teaching Hospital
Names withheld to protect patient privacy
TO THE EDITOR: The article by Senanay-
ake and Ferson1 on detention for tuberculosis
included two case histories. In the case of
“Patient 2”, we believe the details published
were misleading and unnecessarily disclosed
potentially identifying information. This case
was presented in sufficient detail to allow
identification of “Patient 2” by including date
of admission, personal details, city of admis-
sion and details regarding his past history of
alcohol addiction and attempts to self-dis-
charge. All this information was not neces-
sary and did not take into account all the
relevant medical complicating factors.
We were surprised that, as the primary
treating team involved in this patient’s care
over the inpatient stay of 3 months and the
following 6-month outpatient follow-up, we
were not informed of the authors’ plans for
publication, nor requested to comment on
the facts of the report. We were also surprised
to read details of the article in The Sydney
Morning Herald on the day of the article’s
publication in the Journal.2MJA • Volume 183 Number 1 • 4 July 2005 55
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An individual’s right to privacy is a funda-
mental human right. It is unfortunate that the
careful consideration that had been given to
his detention was not extended to publishing
his case details. As Senanayake and Ferson
point out, “Patient 2” recognised that his
human rights were being “infringed” because
he was being held in a “jail cell”, which was a
temporarily modified isolation room in a
public hospital under 24-hour guard.
In law, information provided to a medical
practitioner by a patient becomes subject to a
statutory duty to protect the patient’s privacy
and a common-law duty of confidence is
owed by the treating medical practitioner to
the patient. The NHMRC Guidelines approved
under Section 95A of the Privacy Act 1998
indicate that, when a patient history is pub-
lished, an important principle is that a patient
may not be identified or held up to ridicule.3
Furthermore, public access to medical jour-
nals on the Internet has allowed increased
availability of such reports to the general
public and increases the chance of family
members and others identifying individuals.
The principle of protecting patient privacy
has previously been respected by the Journal.
An article published in 1994  reported a 1979
outbreak of tuberculosis in medical students
who attended an autopsy of an immunosup-
pressed patient with unsuspected active
tuberculosis.4 A report of the incident was
not published contemporaneously, mainly to
protect the privacy of the students involved.
As the report by Senanayake and Ferson
suggests, our patient was socially disadvan-
taged, and several aspects of his behaviour
were probably attributable to a Jarisch–Herx-
heimer reaction in conjunction with acute
alcohol withdrawal. Although we recognise
the need to serve the public interest in health
service management activities, this must be
balanced against the requirement for patient
privacy regardless of social class. We suggest
that the publisher has an obligation to ensure
that patient consent is obtained, and that the
primary treating team has been involved in
the review of case details so that misleading
and potentially identifying information is not
released inappropriately.
1 Senanayake SN, Ferson MJ. Detention for
tuberculosis: public health and the law. Med J
Aust 2004; 180: 573-576. 
2 Locking up TB cases defended. The Sydney
Morning Herald 2004; 7 Jun: 5.
3 National Health and Medical Research Council.
Guidelines approved under Section 95A of the
Privacy Act 1988. Canberra: NHMRC, 2001: 35-
46. Available at: http://www.health.gov.au/
nhmrc/publications/pdf/e43.pdf (accessed Oct
2004).
4 Wilkins D, Woolcock AJ, Cossart YE. Tuberculo-
sis: medical students at risk. Med J Aust 1994;
160: 395-397. ❏
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IN REPLY: We concur with the principle that
patient privacy should be protected in case
reports. As recommended by the International
Committee of Medical Journal Editors,1 meas-
ures in place at the Journal include asking
authors to obtain patient permission for publi-
cation where possible, and directing authors to
remove potentially identifying patient informa-
tion.
The article in question was not a case report.
Case details were given to exemplify the cir-
cumstances that might lead to detention of a
patient for public health reasons in New South
Wales, and dates and some details were
retained to illustrate the temporal flow of the
story. We agree that this may have made the
patient identifiable, if not to the general public,
to himself or his family. We regret this editorial
lapse, and have reworded the patient details in
the electronic version of the article.2
Although chastened by our anonymous col-
leagues’ observations, we are somewhat puz-
zled as to why, given their concern about their
patient’s privacy, they are determined to draw
further attention to the exposing details. We
assume that, in this case (as in the cases of
detaining patients for treatment of tubercu-
losis), public interest prevails.
We also agree that case reports of detailed
clinical histories require the input of the pri-
mary treating team, but the question of author-
ship should be determined by the involved
parties, not the Journal. Be that as it may, as the
article was a public health report (and thus not
meant to be a detailed clinical exposition), we
do not believe that the input of the treating
team was required.
1 International Committee of Medical Journal Editors.
Uniform requirements for manuscripts submitted to
biomedical journals: writing and editing for biomedi-
cal publication, 2004. Available at: http://
www.icmje.org/ (accessed Jun 2005).
2 Senanayake SN, Ferson MJ. Detention for tuberculo-
sis: public health and the law. Med J Aust [Internet
version]. Available at: http://www.mja.com.au/pub-
lic/issues/180_11_070604/sen10776_fm.html
(accessed Jun 2005). ❏
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